Skip to main content
Earnings Labs
Haemonetics Corporation logo

Haemonetics Corporation (HAE)

NYSE·Healthcare·Medical - Devices

$121.90

+1.64%

Mkt Cap $5.46B

Analyst Ratings

Buy

17

Hold

3

Sell

0

Price Target (24 analysts)

$108.60

Range $85.00 – $125.00

Implied Upside

-10.9%

Consensus $108.60 vs current $121.90